Eledon Pharmaceuticals Inc (ELDN)
$2.77 -8.88% Close Oct 30, 2026 Live
Eledon Pharmaceuticals stock today
Eledon Pharmaceuticals closed at $2.77 on October 30, 2026, down 8.88% on the day. Over the past year it returned -36.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $214 million.
$2.00$3.00$4.00
NovJan 2026MarMayJulSep
| Period | ELDN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.5% | -0.9% |
| 3 months | -18.8% | +2.1% |
| Year to date | +83.4% | +11.7% |
| 1 year | -36.3% | +12.4% |
| 3 years | +75.3% | +88.5% |
| 5 years | -44.6% | +76.0% |
Key statistics
- Market value
- $214M
- 52-week range
- $1.39 to $4.36
- Next report
- Nov 13, 2026 (estimated)
About Eledon Pharmaceuticals
Eledon Pharmaceuticals develops monoclonal antibody therapies for transplantation and autoimmune diseases.
Sector: Health Care
More on Eledon Pharmaceuticals
- Returns: what $1,000 became$1,000 ten years ago is $15.40 today
No forecast, no recommendation. This page describes Eledon Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.